Bank of America’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.1M Buy
1,400,965
+329,707
+31% +$2.37M ﹤0.01% 2758
2025
Q1
$6.42M Buy
1,071,258
+1,032,191
+2,642% +$6.18M ﹤0.01% 3018
2024
Q4
$305K Sell
39,067
-462,345
-92% -$3.61M ﹤0.01% 5018
2024
Q3
$5.42M Buy
501,412
+95,095
+23% +$1.03M ﹤0.01% 3135
2024
Q2
$3.43M Sell
406,317
-67,072
-14% -$565K ﹤0.01% 3383
2024
Q1
$3.18M Buy
473,389
+401,742
+561% +$2.7M ﹤0.01% 3408
2023
Q4
$421K Sell
71,647
-71,254
-50% -$419K ﹤0.01% 4734
2023
Q3
$1.39M Sell
142,901
-3,257
-2% -$31.8K ﹤0.01% 3801
2023
Q2
$1.73M Sell
146,158
-227,747
-61% -$2.7M ﹤0.01% 3646
2023
Q1
$4.03M Buy
373,905
+112,499
+43% +$1.21M ﹤0.01% 3172
2022
Q4
$3.02M Buy
261,406
+70,679
+37% +$817K ﹤0.01% 3342
2022
Q3
$2.85M Buy
190,727
+144,807
+315% +$2.16M ﹤0.01% 3362
2022
Q2
$414K Buy
45,920
+10,379
+29% +$93.6K ﹤0.01% 4858
2022
Q1
$266K Sell
35,541
-3,139
-8% -$23.5K ﹤0.01% 5535
2021
Q4
$332K Sell
38,680
-5,383
-12% -$46.2K ﹤0.01% 5385
2021
Q3
$370K Buy
44,063
+26,523
+151% +$223K ﹤0.01% 5053
2021
Q2
$142K Sell
17,540
-7,620
-30% -$61.7K ﹤0.01% 5528
2021
Q1
$221K Buy
25,160
+11,972
+91% +$105K ﹤0.01% 5317
2020
Q4
$148K Buy
13,188
+1,814
+16% +$20.4K ﹤0.01% 5056
2020
Q3
$106K Sell
11,374
-3,506
-24% -$32.7K ﹤0.01% 5049
2020
Q2
$27K Sell
14,880
-835
-5% -$1.52K ﹤0.01% 5590
2020
Q1
$26K Sell
15,715
-7,734
-33% -$12.8K ﹤0.01% 5482
2019
Q4
$68K Sell
23,449
-2,094
-8% -$6.07K ﹤0.01% 5331
2019
Q3
$147K Sell
25,543
-5,128
-17% -$29.5K ﹤0.01% 5052
2019
Q2
$322K Sell
30,671
-12,795
-29% -$134K ﹤0.01% 4635
2019
Q1
$763K Buy
43,466
+18,580
+75% +$326K ﹤0.01% 4078
2018
Q4
$438K Buy
24,886
+2,579
+12% +$45.4K ﹤0.01% 4351
2018
Q3
$919K Sell
22,307
-3,568
-14% -$147K ﹤0.01% 3903
2018
Q2
$1.49M Buy
+25,875
New +$1.49M ﹤0.01% 3620